Free Republic

A new study shows treating these babies with a lower dose of dexamethasone, not only leads to less time on ventilators, but notes its beneficial effects on blood circulation to the lungs, influencing better cardiorespiratory outcomes. Babies born before the 28th week of pregnancy are classed as extremely preterm. To speed up lung development and to allow weaning from ventilator support, these babies are routinely given systemic corticosteroids, such as dexamethasone (Dex), which reduces inflammation and aids ventilation. However, in high doses (5-10mg per kilo for six weeks) Dex can lead to significant thickening of the walls of the heart...

A new drug cocktail is four times more effective at keeping Covid patients out of intensive care, initial tests have suggested. While the steroid dexamethasone was the first drug to be licensed for treating the virus, trials indicate that combining it with heart failure medication spironolactone yields better results. ...The treatment works by ‘turning off’ the impact the virus has on the body, rather than targeting the virus itself.

Despite the lack of good evidence so far, Ivermectin has been taken up by doctors or by individuals self-medicating in countries including Brazil, Bolivia, Peru, South Africa and the US. In the US, provider SingleCare said 817 prescriptions had been filled for Ivermectin (which can also be used to treat skin conditions such as rosacea) in January and February 2021, compared with 92 in the same period last year. Dr Stephen Griffin at the University of Leeds said, "much like hydroxychloroquine before, there has been a considerable amount of off-label use of this drug," based mainly on studies of the...

President Trump’s personal attorney Rudy Giuliani on Tuesday said he’s “pretty much” symptom-free following his COVID-19 diagnosis — and could be getting out of the hospital as soon as tomorrow. The 76-year-old former New York City mayor called into his own WABC radio show, apparently from his bed at Georgetown University Medical Center in Washington D.C. “I’m doing fine,” Giuliani said. “Pretty much all the symptoms are gone.” “I have no fever, I have very little cough, it’s just about also gone, I’ve been walking around, and I think they’re going to let me out tomorrow morning.” Giuliani said he’s...

The fight against COVID-19 has received a major leap following confirmation that the steroid, dexamethasone, has life-saving potential for critically ill COVID-19 patients. World Health Organisation (WHO) Director-General, Tedros Ghebreyesus, said during a recent virtual briefing from Geneva, said the next challenge was how to increase production and rapidly and equitably distribute dexamethasone worldwide, focusing on where it is needed most. According to researchers from Oxford University, a low-dose regimen of dexamethasone, which is typically used to treat certain forms of arthritis, severe allergies, asthma, and certain types of cancer for 10 days was found to reduce the risk of...

Earlier this week researchers in the U.K reported that the inexpensive and commonly‐​used steroid dexamethasone reduced the fatality rate of COVID-19 patients on ventilators by 30 percent. This wonderful news makes a lot of sense to health care practitioners. As we learn more about the workings of the novel coronavirus we now understand that many of the most critical cases result from an over‐​reaction of the patient’s immune system (called a “cytokine storm”) causing inflammation and destruction of tissues and organs that can ultimately lead to death. Steroids have long been employed to counteract acute and chronic immune and hyperimmune...

Another blow for the corporate media and their panic porn about COVID-19. According to scientists in the U.K., the inexpensive and generic dexamethasone is showing life-saving results. This is great news for patients suffering from serve COVID-19 in the future. The sad part is this is a treatment for the symptoms of a cytokine storm, an overactive immune response, not the virus itself. This is frustrating because doctors in the United States have been pushing this theory for months. Pulmonologist Dr. Thomas Yadegar, ICU director of Providence Cedars-Sinai, was treating critically ill patients with powerful anti-inflammatories like dexamethasone based on...

Dexamethasone, a cheap and widely used steroid, has become the first drug shown to be able to save lives among COVID-19 patients in what scientists hailed as a “major breakthrough”. Results of trials announced on Tuesday showed dexamethasone, which is used to reduce inflammation in other diseases, reduced death rates by around a third among the most severely ill COVID-19 patients admitted to hospital. The results suggest the drug should immediately become standard care in patients with severe cases of the pandemic disease, said the researchers who led the trials. “This is a result that shows that if patients who...

A cheap steroid called dexamethasone has been found to reduce the risk of death by up to one-third among coronavirus patients with severe respiratory complications, University of Oxford researchers have said.

A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus. The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say. The drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus. It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth. Had the drug had been used to treat patients in the UK from the start of the pandemic, up to 5,000...